Universal Time: 22:39  |  Local Time: 22:39 (0h GMT)
Select your timezone:

201 - Workshop Session
Design of Xenotransplantation Clinical Trials

Sunday September 13, 2020 | 22:00 to 23:30
Room: Channel 2
Track: Xenotransplantation

Video is available - Log in to view. You must be registered to the event to view content

Presentations

Dr. Chang Ho Yoon, Korea
Cornea

Dr. Kwang-Won Kim, Korea
Naked islets

Prof. Shinichi Matsumoto, Japan
Encapsulated islets

Alfred Joseph Tector, United States
Kidney

Ask a question or make a comment
This will appear in the session question feed in the dashboard

  • Answer to Dr. Cowan.
    Thank you for your question. Based on the results to date, immunosuppressants for corneal xenotransplantation should be used more strongly than those used for corneal allotransplantation (for both T and B cells). Only anti-CD40 Ab- or anti-CD20 Ab/tacrolimus- based immunosuppressive regimen showed efficacy in preclinical study using NHPs. Therefore, in our clinical trial, anti-CD20 Ab/tacrolimus based immunosuppressive regimen will be used.

WebApp Sponsor

© 2020 TTS 2020